Evidence map›Paper›PMID 32815318›Full record

ArticleMolecular genetics & genomic medicine2020

Novel heterozygous truncating titin variants affecting the A-band are associated with cardiomyopathy and myopathy/muscular dystrophy.

Kelly A Rich, Tia Moscarello, Carly Siskind, Guy Brock, Christopher A Tan, Matteo Vatta, Thomas L Winder, Bakri Elsheikh, Leah Vicini, Brianna Tucker and 5 more

Open access · goldAbstract read
In one paragraph

Article in Molecular genetics & genomic medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Analysis ofCirculation. Genomic and precision medicine · 2025
    Article
  5. [Autosomal recessive limb-girdle muscular dystrophy-10. Case report].Revista medica del Instituto Mexicano del Seguro Social · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Molecular insights into titin's A-band.Journal of muscle research and cell motility · 2023
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Kelly A RichThe Ohio State University Wexner Medical Center, The Ohio State University, Columbus, OH, USA.ORCID 0000-0002-0027-0313
Tia MoscarelloStanford Center for Inherited Cardiovascular Disease, Stanford University, Stanford, CA, USA.
Carly SiskindStanford Health Care, Stanford University, Stanford, CA, USA.
Guy BrockThe Ohio State University Center for Biostatistics, The Ohio State University, Columbus, OH, USA.
Christopher A TanInvitae Corporation, San Francisco, CA, USA.
Matteo VattaInvitae Corporation, San Francisco, CA, USA.
Thomas L WinderInvitae Corporation, San Francisco, CA, USA.
Bakri ElsheikhThe Ohio State University Wexner Medical Center, The Ohio State University, Columbus, OH, USA.
Leah ViciniThe Ohio State University Wexner Medical Center, The Ohio State University, Columbus, OH, USA.
Brianna TuckerStanford Center for Inherited Cardiovascular Disease, Stanford University, Stanford, CA, USA.
Marilly PalettasThe Ohio State University Center for Biostatistics, The Ohio State University, Columbus, OH, USA.
Ray E HershbergerThe Ohio State University Wexner Medical Center, The Ohio State University, Columbus, OH, USA.
John T KisselThe Ohio State University Wexner Medical Center, The Ohio State University, Columbus, OH, USA.
Ana MoralesThe Ohio State University Wexner Medical Center, The Ohio State University, Columbus, OH, USA.
Jennifer RoggenbuckThe Ohio State University Wexner Medical Center, The Ohio State University, Columbus, OH, USA.ORCID 0000-0002-6583-9996
The Ohio State University Wexner Medical Center · USInvitae (United States) · USCardiovascular Institute of the South · USThe Ohio State University · USStanford Health Care · US

Funding

The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve HealthUL1TR002733 · NCATS · OHIO STATE UNIVERSITY · PI RINGEL, MATTHEW D · 2018 to 2022
$28.9M
NCATS NIH HHS UL1 TR002733
6 · The paper itself

Abstract

backgroundVariants in TTN are frequently identified in the genetic evaluation of skeletal myopathy or cardiomyopathy. However, due to the high frequency of TTN variants in the general population, incomplete penetrance, and limited understanding of the spectrum of disease, interpretation of TTN variants is often difficult for laboratories and clinicians. Currently, cardiomyopathy is associated with heterozygous A-band TTN variants, whereas skeletal myopathy is largely associated with homozygous or compound heterozygous TTN variants. Recent reports show pathogenic variants in TTN may result in a broader phenotypic spectrum than previously recognized.

methodsHere we report the results of a multisite study that characterized the phenotypes of probands with variants in TTN. We investigated TTN genotype-phenotype correlations in probands with skeletal myopathy and/or cardiomyopathy. Probands with TTN truncating variants (TTNtv) or pathogenic missense variants were ascertained from two academic medical centers. Variants were identified via clinical genetic testing and reviewed according to the American College of Medical Genetics criteria. Clinical and family history data were documented via retrospective chart review. Family studies were performed for probands with atypical phenotypes.

resultsForty-nine probands were identified with TTNtv or pathogenic missense variants. Probands were classified by clinical presentation: cardiac (n = 30), skeletal muscle (n = 12), or both (cardioskeletal, n = 7). Within the cardioskeletal group, 5/7 probands had heterozygous TTNtv predicted to affect the distal (3') end of the A-band. All cardioskeletal probands had onset of proximal-predominant muscle weakness before diagnosis of cardiovascular disease, five pedigrees support dominant transmission.

conclusionAlthough heterozygous TTNtv in the A-band is known to cause dilated cardiomyopathy, we present evidence that these variants may in some cases cause a novel, dominant skeletal myopathy with a limb-girdle pattern of weakness. These findings emphasize the importance of multidisciplinary care for patients with A-band TTNtv who may be at risk for multisystem disease.

Indexed as

PhenotypeAdolescentAdultAgedCardiomyopathiesConnectinFemaleHeterozygoteHumansMaleMiddle AgedMuscle, SkeletalMuscular DystrophiesMutationMyocardiumConnectinTTN protein, humandilated cardiomyopathygenotype-phenotype correlationskeletal myopathyTTNvariant interpretation

Identifiers

PMID32815318
PMCPMC7549586
OpenAlexW3053305040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.